THE ROLE OF INTERVENTIONAL METHODS IN TREATMENT OF PULMONARY EMBOLISM

The presented review concerns to current interventional methods of acute pulmonary embolism treatment. The article provides a rationale for catheter approaches, detailed description of patient selection and risk stratification including an estimation of thromboembolic burden, risk degree of acute pulmonary embolism, bleeding risk assessment, and patient-specific considerations. The review contains the up-to-date classification of pulmonary embolism on the basis of 30-day mortality assessment and estimation of disease outcome according to the conventional and simplified Pulmonary Embolism Severity Index. A special attention is paid to interventional methods peculiarly, in particular to catheter directed thrombolysis, rheolytic thrombectomy, thrombus fragmentation and aspiration. The results of studies concerning efficiency and safety of endovascular methods in treatment of pulmonary embolism patients are reported. It was emphasized importance of further investigation of various clinical aspects using these methods for obtaining of comprehensive information about treatment of the dangerous disease associated with significant morbidity and mortality.

pulmonary embolism, thromboembolism of pulmonary artery, treatment, risk stratification, patient selection, interventional methods, catheter approaches, catheter directed thrombolysis, ultrasound, endovascular treatment

1. Konstantinides S.V., Torbicki A., Agnelli G., et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) endorsed by the european respiratory society (ERS). European Heart Journal. 2014; 35(43): 3033–69, 3069a-3069k. DOI:10.1093/eurheartj/ehu283.

2. Konstantinides S.V., Barco S., Lankeit M., et al. J Am Coll Cardiol. 2016; 67(8): 976-90. doi: 10.1016/j.jacc.2015.11.061.

3. Cohen A.T., Agnelli G., Anderson F.A., et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98(4): 756–64.

4. Raskob G.E., Angchaisuksiri P., Blanco A.N., et al. Thrombosis: a major contributor to global disease burden. Semin. Thromb. Hemost. 2014; 40(07): 724–735.

5. Turetz M., Sideris A.T., Friedman O.A., et al. Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin. Intervent. Radiol. 2018; 35(2): 92-98. doi: 10.1055/s-0038-1642036.

6. Jolly M., Phillips J. Pulmonary embolism: current role of catheter treatment options and operative thrombectomy. Surg. Clin. North. Am. 2018; 98(2): 279-292. doi: 10.1016/j.suc.2017.11.009.

7. Zarghouni M., Charles H.W., Maldonado T.S., et al. Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther. 2016; 6(6): 651-661. doi: 10.21037/cdt.2016.11.15.

8. Jaff M.R., McMurtry M.S., Archer S.L., et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a Scientific Statement from the American Heart Association. Circulation. 2011; 123(16): 1788-830. doi: 10.1161/CIR.0b013e318214914f.

9. Kucher N., Boekstegers P., Muller O.J., et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014; 129(4): 479-86. doi: 10.1161/CIRCULATIONAHA.113.005544.

10. Maslennikov M.A., Sinkevich N.S., Savchenko A.P. Contemporary endovascular methods of treating venous thrombosis and thromboembolism. Consilium Medicum. 2015; 17(5): 44–48. [In Russian]

11. Malyishenko E.S., Popov V.A., Haes B.L., et al. Algorithm of active treatment of acute thromboembolism of pulmonary artery: emphasis on invasiveness. Complex Issues of Cardiovascular Diseases. 2015; 1; 71-77. [In Russian]

12. Jaber W.A., Fong P.P., Weisz G., et al. Acute pulmonary embolism: with an emphasis on an interventional approach. J Am Coll Cardiol. 2016; 67(8): 991-1002. doi: 10.1016/j.jacc.2015.12.024.

13. De Gregorio M.A., Guirola J.A., Lahuerta C., et al. Interventional radiology treatment for pulmonary embolism. World J Radiol. 2017; 9(7): 295-303. doi: 10.4329/wjr.v9.i7.295.

14. Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves healthrelated quality of life. J Vasc Surg. 2000; 32: 130-7.

15. Enden T., Wik H.S., Kvam A.K., et al. Health-related quality of life after catheter-directed thrombolylsis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study. BMJ Open. 2013; 3: e002984.

16. Huisman M.V., Barco S., Cannegieter S.C., et al. Pulmonary embolism. Nat. Rev. Dis. Primers. 2018; 4: 18028. doi: 10.1038/nrdp.2018.28.

17. Abdulyanov I.V., Vagizov I.I., Omelyanenko A.S. Modern therapeutic strategy for the treatment of acute pulmonary thromboembolism. Practical medicine. 2015; 2(36): 35-40. [In Russian]

18. Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353(9162): 1386-1389. doi: 10.1016/S0140-6736(98)07534-5.

19. Kasper W., Konstantinides S., Geibel A., et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997; 30: 1165–1171.

20. Kochmareva E.A., Kokorin V.A., Volkova A.L., et al. High-risk and intermediate-risk predictors of short-term complications of pulmonary thromboembolism. Russian Journal of Cardiology. 2017; 9(149): 7–12. doi: 10.15829/1560-4071-2017-9-7-12. [In Russian]

21. Aujesky D., Obrosky D.S., Stone R.A., et al. Derivation and validation of a prognostic model for pulmonary embolism. Am. J. Respir. Crit. Care Med. 2005; 172: 1041–1046.

22. Miller G.A., Sutton G.C., Kerr I.H., et al. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J. 1971; 2: 681– 684.

23. Jimenez D., Aujesky D., Moores L., et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010; 170: 1383-9. doi: 10.1001/archinternmed.2010.199.

24. Smithburger P.L., Campbell S., Kane-Gill S.L. Alteplase treatment of acute pulmonary embolism in the intensive care unit. Crit Care Nurse. 2013; 33(2): 17-27. doi: 10.4037/ccn2013626.

25. Bhatt A., Al-Hakim R., Benenati J.F. Techniques and devices for catheter directed therapy in pulmonary embolism. Tech Vasc Interv Radiol. 2017; 20(3): 185-192. doi: 10.1053/j.tvir.2017.07.008.

26. Vedantham S., Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.

27. Chiarello M.A., Sista A.K. Catheter-directed thrombolysis for submassive pulmonary embolism. Semin. Intervent. Radiol. 2018; 35(2): 122-128. doi: 10.1055/s-0038-1642041.

28. Meyer G., Vicaut E., Danays T., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014; 370(15): 1402-11. doi: 10.1056/NEJMoa1302097.

29. Konstantinides S., Geibel A., Heusel G., et al. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002; 347(15): 1143-50. 30. Wang T.F., Squizzato A., Dentali F., et al. The role of thrombolytic therapy in pulmonary embolism. Blood. 2015; 125(14): 2191-2199. doi: 10.1182/blood-2014-08-559278.

30. Avgerinos E.D., Saadeddin Z., Abou Ali A.N., et al. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2018; 6(4): 530-540. doi: 10.1016/j.jvsv.2018.03.010.

31. Verstraete M., Miller G.A., Bounameaux H., et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988; 77(2):353-60.

32. Kuo W.T., Banerjee A., Kim P.S., et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT). Chest. 2015; 148(3): 667-673. doi:10.1378/chest.15-0119.

33. Engelberger R.P., Moschovitis A., Fahrni J., et al. Fixed low-dose ultrasound-assisted catheter-directed thrombolysis for intermediate and high-risk pulmonary embolism. Eur Heart J. 2015; 36(10): 597604. doi: 10.1093/eurheartj/eht531.

34. Tapson V.F., Sterling K., Jones N., et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: The OPTALYSE PE Trial. JACC Cardiovasc Interv. 2018; 11(14): 1401-1410. doi: 10.1016/j. jcin.2018.04.008.

35. Devcic Z., Kuo W.T. Percutaneous pulmonary embolism thrombectomy and thrombolysis: technical tips and tricks. Semin. Intervent. Radiol. 2018; 35(2): 129-135. doi: 10.1055/s-0038-1642042.

36. Schmitz-Rode T., Janssens U., Duda S.H., et al. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Cardiol. 2000; 36(2): 375-80.

37. Piazza G., Hohlfelder B., Jaff M.R., et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv. 2015; 8: 1382-92.

38. Kuo W.T. Endovascular therapy for acute pulmonary embolism. J Vasc Interv Radiol. 2012; 23(2): 167-79.

39. Bonvini R.F., Roffi M., Bounameaux H., et al. AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study. EuroIntervention. 2013; 8(12): 1419-27. doi: 10.4244/EIJV8I12A215.

40. Greenfield L.J., Proctor M.C., Williams D.M., et al. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg. 1993; 18: 450-7.

41. Bayiz H., Dumantepe M., Teymen B., et al. Percutaneous aspiration thrombectomy in treatment of massive pulmonary embolism. Heart Lung Circ. 2015; 24(1): 46–54. doi: 10.1016/j.hlc.2014.06.014.

42. Enden T., Haig Y., Kløw N.E., et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012; 379(9810): 31-8. doi: 10.1016/S01406736(11)61753-4.

43. Bashir R., Zack C.J., Zhao H., et al. Comparative outcomes of catheterdirected thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. JAMA Intern Med. 2014; 174: 1494-501.

44. Brailovsky Y., Lakhter V, Zack C., et al. Comparative outcomes of catheter–directed thrombolysis with anticoagulation versus anticoagulation alone in cancer patients with deep venous thrombosis. J Am Coll Cardiol. 2013, 61(10): 932-7. doi: 10.1016/S0735-1097(13)62073-2

45. Brailovsky Y., Zack C., Zhao H., et al. Comparative outcomes of catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of proximal deep vein thrombosis in patients with chronic kidney disease. J Amer Coll Cardiol. 2014, 63(12): 1215-89. DOI: 10.1016/S0735-1097(14)62129-X

46. Jarrett H., Zack C.J., Aggarwal V., et al. Impact of institutional volume on outcomes of catheter directed thrombolysis in the treatment of acute proximal deep vein thrombosis: a 6-year US experience (2005-2010). Circulation. 2015; 132: 1127-35. Doi: 10.1161/CIRCULATIONAHA.115.015555.

47. Vedantham S., Sista A.K., Klein S.J., et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol. 2014; 25(9): 1317-25. doi: 10.1016/j.jvir.2014.04.019.